Hearing-pathway gene activity shifted out of step in mice
An animal experiment compared Alzheimer disease model mice with controls at ages from 50 days after birth to 16 months, finding region-specific patterns.
Limit: Hearing function was not measured alongside gene activity
Researchers compared 5xFAD mice, a model of Alzheimer disease, with control mice in an animal experiment. They measured gene activity in the cochlea, the inner ear’s hearing organ, and three brain regions involved in hearing at 50 days after birth and at 8, 11 and 16 months.
At 50 days, activity related to energy use and protein production was lower than in controls in three regions but shifted in the opposite direction in the fourth. Age-related shifts in inflammation-related gene activity aligned across all four regions at 8 months, diverged at 11 months and aligned again at 16 months. Other gene activity patterns still varied by region at 16 months. The overall response unfolded out of step across regions, rather than following a steady path from ear to brain or brain to ear.
Why it matters
Auditory dysfunction can precede clinical dementia. This molecular map offers a framework for evaluating hearing-related measures as candidate indicators of Alzheimer disease progression.
Caveats
Gene activity patterns alone do not establish whether hearing measures can track disease progression. The findings came from mice and were reported in a preprint that has not been peer-reviewed.
The paper
Yale University Medical School
bioRxiv, Oct 18, 2026, Open access, CC BY-NC-ND, Preprint, not peer-reviewed
